GSK Statement on FDA's Proposed Label Revisions for Some Asthma Medicines - Drugs.com MedNews
Links shared publicly online about this topic.
- 1,368total visits
GSK Statement on FDA's Proposed Label Revisions for Some Asthma Medicines - Drugs.com MedNews
GlaxoSmithKline (NYSE GSK) is reviewing label changes proposed today by the US Food and Drug Administration (FDA) for asthma medications containing long-acting
View full resource at drugs.com
Tags: Asthma, Drug, FDA, GlaxoSmithKline
Most Recently Shared on February 20, 2010 at 12:34 pm By:
GSK Statement on FDA's Proposed Label Revisions for Some Asthma Medicines http://is.gd/8N3VM
Advertisement
